Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT04085562

Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.

Hypertension, Renal Clinical Trial

Official title:
Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.

Clinical Trial Summary

Hypertension is highly prevalent in hemodialysis (HD) patients and leads to increased morbidity and mortality due to cardiovascular disease(CVD). Left ventricular hypertrophy (LVH) is both a manifestation of hypertension caused end-organ damage and an independent risk factor for CVD. Evidence shows that Beta-blockers, especially of low dialyzability decrease risk of CVD and mortality. Calcium channel blockers (CCBs) were also shown to effectively control BP in the volume expanded state and reduce cardiovascular disease risk. Asymmetric dimethyl arginine (ADMA) is a uremic toxin that decreases NO synthesis and is correlated to LVH, carotid intimal thickness (CIT), CVD, and mortality. Amlodipine is shown in one study to significantly reduce ADMA level in HD patients. The purpose of this study is to determine the effect of calcium channel blocker Amlodipine compared to Beta-blocker Bisoprolol on regression of LVH, reduction of ADMA plasma level and on BP control among hypertensive patients on HD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04085562
Study type Interventional
Source Alexandria University
Contact
Status Completed
Phase Phase 4
Start date September 1, 2019
Completion date February 1, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT02095691 - RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157 Phase 1
Recruiting NCT05030987 - Renal Denervation to Treat Heart Failure With Preserved Ejection Fraction N/A
Recruiting NCT05744986 - Transcatheter Renal Artery Sympathetic Denervation Observational Study
Recruiting NCT05743894 - RDN Fesibility Study
Completed NCT05001945 - Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension Phase 2
Recruiting NCT04722159 - Clinical Outcome of Patients With Resistant Hypertension Undergoing Renal Denervation
Completed NCT01756300 - RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension Phase 1
Completed NCT00446251 - Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant Phase 2
Completed NCT00490841 - The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis N/A
Recruiting NCT02432339 - Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress Phase 1/Phase 2
Completed NCT00446459 - Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant. Phase 2
Active, not recruiting NCT05807711 - Efficacy of L-methylfolate and Methylcobalamine in Treating Hypertension and Its Impact on Serum Homocysteine in Hemodialysis Patients With Resistant Hypertension Phase 4